Conversely, wild-type dyskerin protein is upregulated in a number of human cancers, such as in breast, prostate, colon and hepatocellular carcinomas (108, 227–229) and in these cancers, high levels of dyskerin were associated with an aggressive histopathological feature and poor prognosis (229). Here, DKC1 is linked to hepatocellular carcinoma.